Wolfgang Eiermann, MD
Professor of Gynecology
Medical studies in Tübingen and Munich
|1976 - 1982||Residency at the University of Munich Hospital under the direction of Prof. Dr. K. Richter|
|1983 - 1991||Attending Physician, Obstetrics and Gynecology, University of Munich Hospital
Research period at Beth Israel Hospital, Harvard Medical School, Boston
|1991 - 2011||Director of the Frauenklinik vom Roten Kreuz, Munich|
|2001 - present||Medical Director, Frauenklinik vom Roten Kreuz
Certified in gynecological oncology
|2010||Awarded an honorary doctorate by the Petrov Cancer Center, University of St. Petersburg, Russia|
Professor Eiermann is an internationally recognized expert in the treatment of breast cancer and gynecological oncology. While serving as director at the Frauenklinik vom Roten Kreuz, Munich, he established a nationally and internationally recognized center for gynecological oncology alongside the general practice of obstetrics and gynecology. This has since become one of the largest breast cancer treatment centers in Germany.
In addition to his clinical work, he has been particularly active in developing new therapies for breast cancer. He has served as a research director and consultant in a variety of national and international studies on the optimization of breast cancer treatment. He was involved in the clinical development of Herceptin since 1995 and has been an innovator in intraoperative radiotherapy for breast cancers.
Several times, most recently in 2014, Professor Eiermann was named one of Germany's top physicians by the national magazine FOCUS.
His research successes have been documented in scientific publications and book chapters.
Professor Eiermann has now joined the Interdisciplinary Oncology Center and offers medical cancer therapies and comprehensive treatment of all gynecological diseases including surgeries at the neighboring ISAR Klinikum. He continues to serve as an oncology consultant for important pharmaceutical research companies.
Steering Committee Translational Research in Oncology (TRIO) USA
Board member of the Michelangelo Foundation, Milan (Cancer Research)
American Society of Clinical Oncology (ASCO)
German Breast Group (GBG)
International Steering Committee TARGIT Group (London)
Board member of the Walter Schulz Foundation for Medical Research on Cancer
Member of the Tumor Center Munich
Member of the German Society for Gynecology and Obstetrics (DGGG)
Member of the German Society for Senology (DGS)
Editorial and scientific advisory boards of several national and international journals